Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Significance: Although it is commonly accepted that p53-mediated cell-cycle arrest, apoptosis, and senescence all serve as major mechanisms of tumor suppression, accumulating evidence indicates that other activities of p53, such as ferroptosis, are also critical for tumor suppression. However, the molecular mechanisms by which p53-mediated ferroptosis operates are not completely understood. In this study, we discovered that p53 can execute ferroptotic cell-death responses by directly activating its target gene SAT1 , coded for the spermidine/spermine N 1 -acetyltransferase 1. These data indicate a regulatory role of p53 in polyamine metabolism and reveal that p53-mediated activation of SAT1 contributes significantly to ferroptotic responses. Thus, p53 may engage multiple metabolic pathways with ferroptotic cell-death responses for tumor suppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the expression of SAT1 is associated with arachidonate 15-lipoxygenase (ALOX15) levels, and PD146176, an ALOX15 inhibitor, suppresses ferroptosis induced by SAT1.127”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [127]
In the citing paper
“p53 can also activate the expression of SAT1, a rate-limiting enzyme in polyamine catabolism, thereby inducing lipid peroxidation and ferroptosis upon ROS stress.130”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 8×
“In normal cells, the p53 protein is controlled at extremely low levels by its negative regulator MDM2 (32).”
BackgroundMethodInfluentialMice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649 · cited 2×
“Mutations of p53 are present in more than 50% of human cancers, and mice lacking p53 are prone to develop early-onset spontaneous tumors (3, 5).”
BackgroundFerroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · cited 11×
“In response to inappropriate levels of ROS, p53 sensitizes cells to ferroptosis by repressing the transcription of SLC7A11, a component of the cystine/glutamate antiporter (11).”
BackgroundMethodInfluentialSelf-citationMetabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233 · cited 1×
“To support cell growth and proliferation, cancer cells preferentially forgo mitochondrial respiration and become reliant on aerobic glycolysis, which allows the generation of a greater amount of intermediates for de novo biosynthesis (13).”
BackgroundLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Cited by
Items 801–876 of 876
Research Advances in Ferroptosis in Ovarian Cancer: From Mechanism to Therapy
张, 柳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153875
Dysregulation of SIRT1, polyamines and miRNA editing in cancer and aging
Ramamonjiharisoa, M. B., & Liu, S. (2026) · Amino Acids · doi:10.1007/s00726-026-03515-3
Ferroptosis‐Related Gene SAT1 Contributes to Immune Responses in Acute Pancreatitis
Zhou, K., Cai, C., Wan, R., & Wang, X. (2025) · The Journal of Gene Medicine · doi:10.1002/jgm.70063
El papel de la ferroptosis en la enfermedad renal diabética
Peña‐Montes, D. J., & Saavedra‐Molina, A. (2024) · TIP Revista Especializada en Ciencias Químico-Biológicas · doi:10.22201/fesz.23958723e.2024.684
Tian, R. (2020) · eScholarship (California Digital Library)
Cai, D., Cheng, S., Lan, T., Zhang, X., Zhang, X., Ma, X., Jin, H., Abliz, Z., & Wang, Z. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.328
Bonneau, N. (2024) · theses.fr (ABES) · doi:10.70675/601f0632zbb49z4605z8578zad0bb870e560
Elucidating the mechanism of NUPR1 inhibitors in pancreatic cancer treatment
Huang, C. (2021) · theses.fr (ABES) · doi:10.70675/d567c6b8z5273z4d8czba2fz1b589b04e9fe
BindingDB (2026) · UC San Diego · doi:10.7270/q2zg6z57
Dong, X., 侯永坤, Shao, J., Zhu, H.-X., & Liu, J. (2026) · Molecular Medicine Reports · doi:10.3892/mmr.2026.14022
Whitley, O., Delemarre, T., Reyes, M., Kajihara, K. K., Little-Hooy, H., Chen, C., Simone, M. C. D., Xu, M., Shivram, H., Hackney, J. A., et al. (2025) · medRxiv · doi:10.1101/2025.08.21.25333911
He, L., Li, L., Xu, J., Chen, Q., Yang, H., Zhu, J., Liang, L., Zhou, G., & Zhang, M. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04918-0
Sun, Q., Xu, Y., Yuan, F., Qi, Y., Wang, Y., Chen, Q., & Liu, B. (2022) · Figshare · doi:10.6084/m9.figshare.19703967
Sun, Q., Xu, Y., Yuan, F., Qi, Y., Wang, Y., Chen, Q., & Liu, B. (2022) · Figshare · doi:10.6084/m9.figshare.19703970
Sun, Q., Xu, Y., Yuan, F., Qi, Y., Wang, Y., Chen, Q., & Liu, B. (2022) · Figshare · doi:10.6084/m9.figshare.19703964
Sun, Q., Xu, Y., Yuan, F., Qi, Y., Wang, Y., Chen, Q., & Liu, B. (2022) · Figshare · doi:10.6084/m9.figshare.19703946
Sun, Q., Xu, Y., Yuan, F., Qi, Y., Wang, Y., Chen, Q., & Liu, B. (2022) · Figshare · doi:10.6084/m9.figshare.19703955
Sun, Q., Xu, Y., Yuan, F., Qi, Y., Wang, Y., Chen, Q., & Liu, B. (2022) · Figshare · doi:10.6084/m9.figshare.19703949
Sun, Q., Xu, Y., Yuan, F., Qi, Y., Wang, Y., Chen, Q., & Liu, B. (2022) · Figshare · doi:10.6084/m9.figshare.19703961
Sun, Q., Xu, Y., Yuan, F., Qi, Y., Wang, Y., Chen, Q., & Liu, B. (2022) · Figshare · doi:10.6084/m9.figshare.19703952
Sun, Q., Xu, Y., Yuan, F., Qi, Y., Wang, Y., Chen, Q., & Liu, B. (2022) · Figshare · doi:10.6084/m9.figshare.19703958
Oturkar, C. C., Junhoung Park, J., Ijaz, I., Adams, C., Mukhopadhyay, U. K., Dolan, M., Caradori, A., Oshi, M., Zhang, Y., Wang, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.21.760572
Xu, F., Xu, X., Yang, Y., & Song, X. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s638426
Ma, X., Mai, Z., Zhou, B., Wang, M., Xia, W., Zhang, M., & Song, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1801813/v1
Liu, Q. F., Zheng, W., Yang, Y., Liang, G., Tang, W., Zhang, C., Wang, J., Zhong, X., & Xu, C. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117991
Bagheri, R. (2022) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
ALOX5 promotes esophageal squamous cell carcinoma radiosensitization by ferroptosis
Dai, K., & Ding, Y. (2023) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2023.100665
Zhao, Y.-Q., Zhou, F.-J., Duan, X.-L., Huang, A.-Y., Xiang, Z.-R., Zhao, Y.-H., Ding, X., & Hao, X. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01938-y
Ge, C., Zhang, S., Mu, H., Zheng, S., Tan, Z., Huang, X., Xu, C., Zou, J., Zhu, Y., Feng, D., et al. (2022) · doi:10.3389/fcell.2021.774957.s002
Zhu, K., Lang, Z., Zhan, Y., Tao, Q., Yu, Z., Chen, L., Fan, C., Jin, Y., Yu, K., Zhu, B., et al. (2022) · doi:10.3389/fonc.2022.1023040.s001
Interconnected death: crosstalk among ferroptosis, cuproptosis, and pyroptosis in cancer
Liu, Y., Liu, J., Zeng, D., Chen, L., Wei, C., Qiu, X., Fu, L., & Deng, Z. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02799-z
Delivery of SiRNA with Drugs Targeting Polyamine Metabolism as Combinational Cancer Treatment
Yu, A. (2021) · DigitalCommons@UNMC
Nalla, L. V., & Gajula, S. N. R. (2026) · Authorea · doi:10.22541/au.176916440.02425728/v1
Regulation of p53 target gene transcription by a TBL1-mediated epigenetic mechanism
Wu, Q. (2019) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00026968
Elucidating the molecular mechanisms of the antioxidant function of CoA and protein CoAlation
Yu, B. Y. K. (2024) · UCL Discovery (University College London)
Region terminalny 5’ mRNA p53 u myszy: struktura i funkcja
(n.d.) · RCIN (Digital Repository of the Scientifics Institutes) (Institute of Archaeology and Ethnology of the Polish Academy of Sciences)
Regulation of ferroptosis by inter-organellar metabolic signaling network
Zhang, L., Zhao, Z. B., Li, W., & Zhu, J. (2026) · Ferroptosis and Oxidative Stress · doi:10.70401/fos.2026.0038
Shi, J., Fan, F., Wang, J., Zheng, G., Runchen, Z., Guo, L., Zhang, X., Wang, Y., & Ma, C. (2026) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.190
Hepatocellular carcinoma’s inflammatory secret: ferroptosis as the key
Caro, A. A., LoBianco, F. V., & Aykin‐Burns, N. (2026) · Translational Cancer Research · doi:10.21037/tcr-2025-1684
A Review on Ferroptosis an Emerging Form of Regulated Cell Death and Its Pharmacological Relevance
Sunayana, R., Shashank, J., Payal, R., & Rishabh, C. (2026) · International journal of research and scientific innovation · doi:10.51244/ijrsi.2026.1306000289
Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3
神徳, 亮. (2017) · Institutional Repositories DataBase (IRDB)
NRF/CNC Proteins Mediate Ferroptosis in Diseases
Zhang, C. (2024) · Current Trends in Biomedical Engineering & Biosciences · doi:10.19080/ctbeb.2024.22.556081
Huang, A., Li, T., Xie, X., & Xia, J. (2021) · doi:10.3389/fmolb.2021.759173.s004
Zhou, Y., Yang, X., Zhang, B., Li, J., Wu, Y., & Yu, J. (2026) · BMC Neurology · doi:10.1186/s12883-026-04684-0
Li, Y., & Tao, Y. (2026) · PubMed Central · doi:10.11817/j.issn.1672-7347.2026.260457
Liu, X., Xu, Z., Cheng, F., Hu, S., He, M., Zheng, W., Wei, H., Li, J., Yang, H., Fang, L., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.109676
Zhang, T., Huang, Y., Cheng, P., Qin, S., Cao, Y., Xie, M., & Wang, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1934498
Advances in Ferroptosis and Kidney Disease
李, 梦. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122860
Baldi, S., He, Y., Ivanov, I., Sun, Y., Feng, W., Refat, M., Mohammed, S. A. D., Adlat, S., Tian, Z., Wang, Y., et al. (2022) · doi:10.3389/fmolb.2022.1102735.s001
含硫アミノ酸と細胞死の関係 S-アデノシルメチオニン代謝による鉄依存性細胞死フェロトーシス誘導機構の解明
多田, 圭. (2023) · Institutional Repositories DataBase (IRDB)
Ferroptosis: A Mechanism for Programmed Cell Death
Chadha, S. (2026) · The American Journal of Applied Sciences · doi:10.37547/tajas/warm-02
Xu, R., He, C., FENG, S., Cai, Y., Zhao, Q., Xin, G., Zhang, Q., Qin, L., & Wang, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1935866
Cheng, K., Guo, Q., Shen, Z., Yang, W., Zhou, Y., Sun, Z., Yao, X., & Wu, H. (2022) · doi:10.3389/fonc.2022.948389.s001
Kato, M. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.15083/0002009150
Liu, Y., Shou, Y., Zhu, R., Qiu, Z., Zhang, Q., & Xu, J. (2022) · doi:10.3389/fcell.2022.818457.s001
CLINICAL AND DIAGNOSTIC SIGNIFICANCE OF SPERMIN IN PROSTATE CANCER (LITERATURE REVIEW)
Nikolaev, A. A., & Sakharov, M. E. (2023) · Современные проблемы науки и образования · doi:10.17513/spno.32427
High termination activity negatively influences nonsense suppression
Bhat, S. Y., Bhattacharya, A. A., Li, H., Lueck, J. D., Goldman, Y. E., & Cooperman, B. S. (2024) · Biophysical Journal · doi:10.1016/j.bpj.2023.11.1963
Kardana, L., & Kazan, H. H. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3955.c2662
SAT1-Mediated Spermidine Metabolism Drives Ferroptosis in Cervical CancerPreprint
Peng, X., zhen, J., yuan, W., yin, Y., Zhang, J., Lu, M.-D., & Chen, D. J. (2026) · Research Square · doi:10.21203/rs.3.rs-8200678/v1
Kim, J. M., Kim, Y., Na, H., Kim, J. H., Lee, S., & Sung, M. J. (2026) · Food Science and Biotechnology · doi:10.1007/s10068-026-02185-x
Li, Y., Zhou, S., Li, R., Liu, Y., Guo, X., Peng, L., Liu, Y., Li, M., Zhao, L., Zhang, Y., et al. (2026) · Translational Cancer Research · doi:10.21037/tcr-2026-1-0145
Zhou, M., Wang, X., Wu, Y., Yang, W., Liu, S., Liu, X., Chen, Q., Cai, C., Zhao, Y., Guo, X., et al. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109563
Li, H., Huang, L., Song, F., Pan, X., Zhao, G., Xiong, J., Song, P., Zhao, L., Yu, X., Zhang, J., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1934107
Nakao, M., Fukuzawa, M., Sunamura, M., Shinohara, H., Naito, S., Kono, S., Yamauchi, Y., Madarame, A., Uchida, K., Morise, T., et al. (2026) · Medical Sciences · doi:10.3390/medsci14070695
Zhang, Y., Wu, Y., Ren, Y., Yang, Z., Lian, J., & XiaoLi, L. (2026) · Medical Science Monitor · doi:10.12659/msm.954635
Elahi, M., Song, S., Shen, W., Chen, A. W., Hassan, M. M., Islam, M. S., Reece, E. A., Roychaudhuri, R., Wang, G., Zeng, L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.11.03.764065
Li, Z., Wu, Y., Yang, W., Wang, W., Li, J., Huang, X., Yang, Y., Zhang, X., & Ye, X. (2024) · doi:10.3389/fcell.2024.1331759.s004
Wang, K., Song, Y., Li, H., Song, J., & Wang, S. (2022) · doi:10.3389/fcvm.2022.991613.s002
Self-citationLiu, J., Wang, Y., Meng, H., Yin, Y., Zhu, H., & Ni, T. (2021) · doi:10.3389/fcell.2021.735013.s005
Qiu, L., Zhou, R., Luo, Z., Wu, J., & Jiang, H. (2022) · doi:10.3389/fonc.2022.774458.s004
Yin, H., Lin, M., Liang, S., Wei, M., Huang, C., Qin, F., Nong, J., Zeng, X., Nong, C., & Qin, H. (2022) · doi:10.3389/fonc.2022.988867.s001
Fan, D., Ma, X., & Hao, S. (2026) · Integrative Cancer Therapies · doi:10.1177/15347354261510045
Zelin, J., Zhang, Y., Yin, W., Gao, A., Pan, Z., Wang, Y., Liu, Y., Yu, Z., Hao, Y., & Liu, J. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.2024399
Metadata
- Authors
- Ou, Y., Wang, S.-J., Li, D., Chu, B., & Gu, W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2016-10-03
- Volume
- 113
- Issue
- 44
- Pages
- E6806-E6812
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2527907612
- Cited by
- 765
- References
- 43
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.